AVIGBAGENE PARVEC
UNII 4UNG7LZ675

Substance Identification & Data

This profile provides standardized clinical and technical data for Avigbagene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4UNG7LZ675.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3053069-19-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4UNG7LZ675

CAS Registry Number

3053069-19-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AVIGBAGENE PARVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224717

National Cancer Institute reference terminology for clinical and research data.

INN ID

13934

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-78

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Avigbagene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AVIGBAGENE PARVEC

Common Names & Synonyms

AAV2/S3-HCR-HAAT-GBACO VARIANT 85. AAV2/S3 DESCRIBES THE CAPSID AND HCR-HAAT-GBACO VARIANT 85 DESCRIBES THE DNA GENOME.

AVIGBAGENE PARVEC [INN]

AVIGBAGENE PARVEC [USAN]

CAPSOMERE, RECOMBINANT ADENO-ASSOCIATED VIRUS 8/ADENO-ASSOCIATED VIRUS 3B VIRAL CAPSID VP1, COMPLEX WITH ADENO-ASSOCIATED VIRUS 3B VIRAL CAPSID PROTEIN VP2, COMPLEX WITH ADENO-ASSOCIATED VIRUS 3B VIRAL CAPSID PROTEIN VP3 DECAMER, HEXACONTAMER, COMPLEX WITH DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS 2 DERIVED VECTOR HUMAN APOLIPOPROTEIN E GENE HEPATIC CONTROL LOCUS REGION PLUS HUMAN TRYPSIN-INHIBITING PROTEIN SERPIN A1 GENE PROMOTER PLUS SIMIAN VIRUS 40 INTRON PLUS HUMAN GLUCOSYLCERAMIDASE (351-CYSTEINE, 380-CYSTEINE) CODON-OPTIMIZED GENE PLUS BOVINE SOMATOTROPIN GENE POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS) (1:1). THE DRUG SUBSTANCE IS AN ADENO-ASSOCIATED VIRUS COMPOSED OF 2 ELEMENTS: A SINGLE-STRANDED DNA VECTOR GENOME WHICH IS PACKAGED IN AN ADENO-ASSOCIATED VIRUS-DERIVED CAPSID

FLT201 COMPRISES TWO COMPONENTS: THE S3 (AAVS3) VIRAL CAPSID INTO WHICH IS PACKAGED THE SINGLE STRANDED 3046 NUCLEOTIDE FRE76-GBACO VARIANT 85-BGPA GENOME

Technical Codes

FLT201

FLT-201

External Clinical & Regulatory Resources

Previous UNII4UN9AOU6G8

Next UNII4UO44T09QM